Gregory M. Pastores

13.7k citations

204 papers · 8.8k indexed · h-index 50

Physiology top 0.1%
- Lysosomal Storage Disorders Research 172
Cell Biology top 0.2%
- Cellular transport and secretion 53
Rheumatology top 0.5%
- Glycogen Storage Diseases and Myoclonus 25
Epidemiology top 0.5%
- Trypanosoma species research and implications 63
Organic Chemistry top 0.5%
- Carbohydrate Chemistry and Synthesis 60
Molecular Biology
- Glycosylation and Glycoproteins Research 35
- Studies on Chitinases and Chitosanases 14
- Mitochondrial Function and Pathology 10

Co-authors: Edwin H. Kolodny Pramod K. Mistry Neal J. Weinreb Paige Kaplan Joel Charrow Rebecca S. Wappner Michael Beck Barry E. Rosenbloom
Cited by: Physiology Cell Biology Rheumatology
Journals: The Lancet (1 paper)Journal of Clinical Investigation (2 papers)SHILAP Revista de lepidopterología (2 papers)
Partner nations: United States United Kingdom Ireland

In The Last Decade

Gregory M. Pastores

199 papers receiving 8.5k citations

Peers

Countries citing papers authored by Gregory M. Pastores

Since Specialization

Citations

This map shows the geographic impact of Gregory M. Pastores's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory M. Pastores with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory M. Pastores more than expected).

Fields of papers citing papers by Gregory M. Pastores

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory M. Pastores. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory M. Pastores. The network helps show where Gregory M. Pastores may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Gregory M. Pastores, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gregory M. Pastores Line = papers co-authored together Gregory M. Pastores links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The COVID-19 pandemic impact on continuity of care provision on rare brain diseases and on ataxias, dystonia and PKU. A scoping review Orphanet Journal of Rare Diseases ·Sara Cannizzo,Vinciane Quoidbach,Paola Giunti,Wolfgang H. Oertel,Gregory M. Pastores,Maja Relja,Giuseppe Turchetti	2024	1
2	Pharmacological treatment of pediatric Gaucher disease Expert Review of Clinical Pharmacology ·Punita Gupta,Gregory M. Pastores	2018	22
3	Cardiopulmonary Exercise Testing Reflects Improved Exercise Capacity in Response to Treatment in Morquio A Patients: Results of a 52-Week Pilot Study of Two Different Doses of Elosulfase Alfa JIMD Reports ·Kenneth I. Berger,Barbara K. Burton,Gregory D. Lewis,Mark A. Tarnopolsky,Paul Harmatz,John J. Mitchell,Nicole Muschol,Simon Jones,V. Reid Sutton,Gregory M. Pastores,Heather Lau,Rebecca Sparkes,Adam J. Shaywitz	2017	4
4	Home infusion of intravenous velaglucerase alfa: Experience from pooled clinical studies in 104 patients with type 1 Gaucher disease Molecular Genetics and Metabolism ·Deborah Elstein,T. Burrow,Joel Charrow,Pilar Giraldo,Atul Mehta,Gregory M. Pastores,Hak‐Myung Lee,Björn Mellgård,Ari Zimran	2016	9
5	A Phase 3, multicenter, open-label, switchover trial to assess the safety and efficacy of taliglucerase alfa, a plant cell-expressed recombinant human glucocerebrosidase, in adult and pediatric patients with Gaucher disease previously treated with imiglucerase Gregory M. Pastores,Мilan Petakov,Pilar Giraldo,Hanna Rosenbaum,Jeff Szer,Patrick Deegan,Dominick Amato,Eugen Mengel,Ee Shien Tan,Raul Chertkoff,Einat Brill‐Almon,Ari Zimran	2014	1
6	Juvenile-onset motor neuron disease caused by novel mutations in β-hexosaminidase Molecular Genetics and Metabolism ·Tyler Mark Pierson,Paola Torres,Bei-Jin Zeng,Allan M. Glanzman,David Adams,Richard S. Finkel,Don J. Mahuran,Gregory M. Pastores,Gihan Tennekoon,Edwin H. Kolodny	2012	3
7	Four-Year Prospective Clinical Trial of Agalsidase Alfa in Children with Fabry Disease The Journal of Pediatrics ·Raphael Schiffmann,Rick A. Martin,Tyler Reimschisel,Karen Johnson,Victoria L. Castañeda,Yeong‐Hau H. Lien,Gregory M. Pastores,Christoph Kampmann,Markus Ries,Joe T.R. Clarke	2010	49
8	Effects of enzyme replacement therapy in Fabry disease—A comprehensive review of the medical literature Genetics in Medicine ·Olivier Lidove,Michael L. West,Guillem Pintos‐Morell,Ricardo Reisin,Kathy Nicholls,Luis E. Figuera,Rossella Parini,Luiz Roberto Carvalho,Christoph Kampmann,Gregory M. Pastores,Atul Mehta	2010	90
9	Multiple sulfatase deficiency: clinical report and description of two novel mutations in a Brazilian patient Metabolic Brain Disease ·Osvaldo Artigalás,Luiz Roberto da Silva,Maira Burin,Gregory M. Pastores,Bai Jin Zeng,Nívea De Macedo,Ida Vanessa Döederlein Schwartz	2009	8
10	Mild‐onset presentation of Canavan's disease associated with novel G212A point mutation in aspartoacylase gene Annals of Neurology ·Christopher G. Janson,Edwin H. Kolodny,Baijin Zeng,Srinivasa Raghavan,Gregory M. Pastores,Paola Torres,Mitra Assadi,Scott McPhee,Olga Goldfarb,Beth Saslow,Andrew Freese,Dihao Wang,Larissa T. Bilaniuk,David Shera,Paola Leone	2006	35
11	Management of patients with Gaucher's disease: Clinical perspectives European Journal of Internal Medicine ·Gregory M. Pastores	2006	1
12	Individualization of long-term enzyme replacement therapy for Gaucher disease Genetics in Medicine ·Hans C. Andersson,Joel Charrow,Paige Kaplan,Pramod K. Mistry,Gregory M. Pastores,Ainu Prakesh-Cheng,Barry E. Rosenbloom,C. Ronald Scott,Rebecca S. Wappner,Neal J. Weinreb	2005	89
13	High Prevalence of the 55-bp Deletion (c.1263del55) in Exon 9 of the Glucocerebrosidase Gene Causing Misdiagnosis (for Homozygous N370S (c.1226A > G) Mutation) in Spanish Gaucher Disease Patients Blood Cells Molecules and Diseases ·Miguel Ángel Torralba,Pilar Alfonso,Juan Ignacio Pérez‐Calvo,Ana Cenarro,Gregory M. Pastores,Pilar Giraldo,F. Civeira,Miguel Pocovı́	2002	12
14	Rapid Detection of the Two Common Mutations in Ashkenazi Jewish Patients with Mucolipidosis Type IV Genetic Testing ·Zhaohui Wang,Baijin Zeng,Gregory M. Pastores,Natte Raksadawan,Elton Ong,Edwin H. Kolodny	2001	10
15	Recommendations for Diagnosis, Evaluation, and Monitoring of Patients With Gaucher Disease JAMA Internal Medicine ·Joel Charrow,Joan A. Esplin,Paige Kaplan,Edwin H. Kolodny,Gregory M. Pastores,C. Ronald Scott,Rebecca S. Wappner,Neal J. Weinreb,Jeffrey S. Wisch	1999	1
16	Identification and expression of acid beta-glucosidase mutations causing severe type 1 and neurologic type 2 Gaucher disease in non-Jewish patients. Journal of Clinical Investigation ·Marie Grace,Robert J. Desnick,Gregory M. Pastores	1997	40
17	Scintigraphic evaluation of Tc‐99m‐low‐density lipoprotein (LDL) distribution in patients with Gaucher disease Clinical Genetics ·Mordechai Lorberboym,Shankar Vallabhajosula,H Lipszyc,Gregory M. Pastores	1997	5
18	Regression of skeletal changes in type 1 Gaucher disease with enzyme replacement therapy Skeletal Radiology ·Gregory M. Pastores,George Hermann,Karen I. Norton,Mordechai Lorberboym,Robert J. Desnick	1996	16
19	Management of Gaucher disease. Current status and future directions: A roundtable discussion. Seminars in Hematology ·S. A. Duursma,Johannes M. F. G. Aerts,Nadia Belmatoug,Timothy M. Cox,Tom Einhorn,Joan A. Esplin,Carla E. M. Hollak,C. Incerti,Gregory M. Pastores,R. Rademakers,Rina Zaizov	1995	38
20	Autosomal dominant supravalvular aortic stenosis: localization to chromosome 7 Human Molecular Genetics ·Timothy M. Olson,Virginia V. Michels,Noralane M. Lindor,Gregory M. Pastores,JamesL. Weber,DanielJ. Schaid,David J. Driscoll,Robert Feldt,Stephen N. Thibodeau	1993	48

About Gregory M. Pastores

Gregory M. Pastores is a scholar working on Physiology, Cell Biology and Organic Chemistry, having authored 204 papers that have together received 8.8k indexed citations. Recurring topics across this work include Lysosomal Storage Disorders Research (172 papers), Trypanosoma species research and implications (63 papers), Carbohydrate Chemistry and Synthesis (60 papers), Cellular transport and secretion (53 papers), Glycosylation and Glycoproteins Research (35 papers), Glycogen Storage Diseases and Myoclonus (25 papers), Studies on Chitinases and Chitosanases (14 papers) and Mitochondrial Function and Pathology (10 papers). The work is most often cited by research in Physiology (7.5k citations), Cell Biology (2.8k citations) and Rheumatology (1.4k citations). Gregory M. Pastores has collaborated with scholars based in United States, United Kingdom and Ireland. Frequent co-authors include Edwin H. Kolodny, Pramod K. Mistry, Neal J. Weinreb, Paige Kaplan, Joel Charrow, Rebecca S. Wappner, Michael Beck, Barry E. Rosenbloom, Hans C. Andersson and Ari Zimran. Their work appears in journals such as The Lancet, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact